'S­mooth and very much on track': Ei­sai re­ports first ship­ments of Leqem­bi

Ei­sai and Bio­gen be­gan ship­ping out dos­es of their new­ly ap­proved Alzheimer’s drug Leqem­bi ahead of sched­ule last month, ac­cord­ing to Ei­sai’s US chair­man and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER